Holly Cairns (Cork South West, Social Democrats)
Link to this: Individually | In context | Oireachtas source

1469. To ask the Minister for Health the steps he is taking to address the high cost of long-acting contraception which is even more challenging to overcome economic uncertainty and limited freedom of movement during the Covid-19 pandemic; and if he will make a statement on the matter. [14336/21]

Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

Eligibility for access to contraceptive products is currently governed by the same eligibility framework as applies more broadly in the Irish healthcare system, and the supports available to individuals in terms of mitigating the cost of LARCs are also the same.  

Those who hold a medical card can access contraception, including LARCs, free of charge except for a €1.50 per item prescription charge levied at the pharmacy. In addition, those who possess GP visit cards can see their doctor without charge, effectively removing the clinical cost associated with LARCs, although the individual would still have to pay for the product itself.

For those not in possession of either a medical card or GP visit card, contraception is considered as an out-of-pocket expense.  However, the Drug Payment Scheme covers in full the cost of prescribed medication in excess of €114 a month for an individual or family which can serve to limit this cost. 

I would also stress that, despite the delay caused by the need to focus on and prioritise the response to the current pandemic, it remains a commitment of this Government to expand access to free contraception for women aged 17-25, including LARCs.